 | Up a level |
Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; ... (2024). Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. (In Press). The lancet Elsevier 10.1016/S0140-6736(24)00184-3
Vidal, Liat; Gafter-Gvili, Anat; Salles, Gilles; Dreyling, Martin H.; Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Pettengell, Ruth; Witzens-Harig, Mathias; Shpilberg, Ofer (2011). Rituximab maintenance for the treatment of patients with follicular lymphoma: An updated systematic review and meta-analysis of randomized trials. Journal of the National Cancer Institute JNCI, 103(23), pp. 1799-1806. Cary, N.C.: Oxford University Press 10.1093/jnci/djr418
Vidal, Liat; Gafter-Gvili, Anat; Leibovici, Leonard; Dreyling, Martin; Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Cohen, Amos; Shpilberg, Ofer (2009). Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials. Journal of the National Cancer Institute JNCI, 101(4), pp. 248-255. Cary, N.C.: Oxford University Press 10.1093/jnci/djn478
